Today

Novo Nordisk News

All news where Novo Nordisk is mentioned

Zepbound tops Wegovy for weight loss in Eli Lilly study

Zepbound tops Wegovy for weight loss in Eli Lilly study

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study

Novo Nordisk wants to boost India GCC capacity, but no plans for production unit

Novo Nordisk wants to boost India GCC capacity, but no plans for production unit

KKR to buy Healthium Medtech for Rs 7000 cr from Apax

KKR to buy Healthium Medtech for Rs 7000 cr from Apax

US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition

US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition

Is the global battle against obesity an opportunity for investors?

Is the global battle against obesity an opportunity for investors?

Nasdaq, S&P 500 futures inch up ahead of more economic data, Powell testimony

Nasdaq, S&P 500 futures inch up ahead of more economic data, Powell testimony

Eli Lilly could launch obesity drug in India next year, CEO says

Eli Lilly could launch obesity drug in India next year, CEO says

Eli Lilly Pushes Tesla Off From the Magnificent 7 - But Can It Stay There?

Eli Lilly Pushes Tesla Off From the Magnificent 7 - But Can It Stay There?

Drugmakers Raise Prices of Ozempic, Mounjaro and Hundreds of Other Drugs

Drugmakers Raise Prices of Ozempic, Mounjaro and Hundreds of Other Drugs

France, Germany shares hit record highs, but give up gains after U.S CPI

France, Germany shares hit record highs, but give up gains after U.S CPI

Pfizer nixes more study of twice-daily obesity pill treatment

Pfizer nixes more study of twice-daily obesity pill treatment

Novo Nordisk, maker of Ozempic and Wegovy sues two pharmacies for ‘selling impure drugs’

Novo Nordisk, maker of Ozempic and Wegovy sues two pharmacies for ‘selling impure drugs’

Lilly to build $2.5 billion Germany plant as obesity drug demand soars

Lilly to build $2.5 billion Germany plant as obesity drug demand soars

Novo Nordisk says Wegovy heart benefits due to more than weight loss

Novo Nordisk says Wegovy heart benefits due to more than weight loss

Lilly cuts annual profit view on M&A charges; Mounjaro boosts Q3 sales

Lilly cuts annual profit view on M&A charges; Mounjaro boosts Q3 sales

Denmark's Novo Nordisk and South Africa's Aspen sign a deal to produce insulin for African patients

Denmark's Novo Nordisk and South Africa's Aspen sign a deal to produce insulin for African patients

Eli Lilly sues US medical spas, compounding pharmacies, wellness centers over sales of bogus Mounjaro for weight loss

Eli Lilly sues US medical spas, compounding pharmacies, wellness centers over sales of bogus Mounjaro for weight loss

Supply problems and insurance issues make popular weight-loss drugs hard to get

Supply problems and insurance issues make popular weight-loss drugs hard to get

The Obesity Drug Revolution Just Got Real

The Obesity Drug Revolution Just Got Real

Biggest pharma blockbuster? All about Wegovy, Novo Nordisk's obesity drug, that cuts risk of heart attacks and strokes by 20%

Biggest pharma blockbuster? All about Wegovy, Novo Nordisk's obesity drug, that cuts risk of heart attacks and strokes by 20%

1
2
Next

About Us

Fvbb.com is an aggregator of the latest financial news in your feed. Be the first to know everything concerning financial analyzes, currency, world economy, investments and even much more. The latest financial news from the leading news agencies around the world at one place for your comfort. 300+ information resources are here on our site, that give you the opportunity to save time on search. Just actual news 24/7 non-stop! Stay tuned and we will keep you informed!

Owner: SNOWLAND s.r.o.
Registration certificate 06691200
Address:
Snowland s.r.o.
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
Czech Republic

Categories

Info

For advertisers

Advertising Questions ?

Add news

Add Source

©2025. All rights reserved.

DMCA